Australia invests $3.6m to develop newborn screening platform | Healthcare Asia Magazine
, Australia
Photo from Envato

Australia invests $3.6m to develop newborn screening platform

The new platform is set to undergo a 12-month research trial.

Australia has invested approximately $3.6m (A$5.5m) for researchers at the University of New South Wales to establish a platform for newborn screening.

Through the funding, the platform will undergo a 12-month research trial and is set to screen 24 genetic conditions in Queensland's newborns.

This includes illnesses such as biotinidase deficiency, haemophilia, cystic fibrosis, spinal muscular atrophy and severe combined immunodeficiency.

According to the government, this initiative aims to shorten diagnosis timeframes to deliver urgent care for infants and promote early intervention.

A$1 = $0.66

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!